NCT00683501View on ClinicalTrials.gov

Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions
Ocular HypertensionElevated IOPGlaucoma
Interventions
DRUG

DNB-001

four dosages of DNB-001, one placebo dosage

Trial Locations (1)

SN14 6NQ

Omnicare Clinical Research Center, Chippenham

Sponsors
All Listed Sponsors
lead

Danube Pharmaceuticals, Inc.

INDUSTRY